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Introduction
With an aging population that continues to grow, many pa-
tients have cardiovascular risk factors or preexisting cardiovas-
cular disease at the time of non-cardiac surgery. Among various 
diagnostic imaging modalities for cardiovascular disease, trans-
thoracic echocardiography is one of the most popular methods 
for preoperative cardiac risk stratification because it can simulta-
neously evaluate cardiac structures and the function of the heart 
[1]. Moreover, it is safe, reproducible, cost-effective, and easy to 
perform. Thus, echocardiography is used widely and its poten-
tial applications are increasing with advances in technology. Ap-
propriate knowledge regarding indications for echocardiography 
in the current guidelines, applications of echocardiography in 
real clinical practice, and a correct understanding of commonly 
encountered echocardiographic findings might help to manage 
patients in the perioperative period, and occasionally rescue 
patients from acute manifestations of overt cardiovascular dis-
eases, such as decompensated heart failure or cardiogenic shock.
Current Guidelines: When to Perform 
Preoperative Echocardiography? 
Current guidelines, in fact, do not recommend routine trans-
thoracic echocardiography for the evaluation of cardiac function 
before non-cardiac surgery. Table 1 summarizes the recommen-
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dations for echocardiography before non-cardiac surgery in sev-
eral guidelines. The British Society of Echocardiography guide-
lines [2], published in April 2013, comprehensively stated the 
clinical indications for echocardiography for elective and semi-
urgent surgery. In this guideline, four indications are specified: 
(1) documented ischemic heart disease with reduced functional 
capacity (< 4 metabolic equivalents [METs]), (2) unexplained 
shortness of breath in the absence of clinical signs of heart fail-
ure if the electrocardiogram and/or chest X-ray is abnormal, (3) 
murmur in the presence of cardiac or respiratory symptoms, and 
(4) murmur in an asymptomatic individual in whom clinical 
features or other investigations suggest severe structural heart 
disease. To meet these indications, we need a properly taken 
history showing any previous ischemic heart disease and an 
accurate physical examination, including auscultation. In fact, 
today, primary physicians’ and trainees’ ability to hear cardiac 
murmur may be poor, as various imaging modalities have been 
developed. In real clinical practice in Korea, many hospitals 
have their own practical standards for performing preoperative 
echocardiography before non-cardiac surgery. For example, in 
elderly patients without a completely normal electrocardiogram 
or chest X-ray, many physicians request preoperative echocar-
diography. However, repeated assessments versus a previous 
echocardiogram with no intervening change in clinical status 
and routine preoperative echocardiography are not indicated.
In the guidelines of the American Society of Echocardiogra-
phy [3], there is no clear defined indication for resting echocar-
diograms. Additionally, the American College of Cardiology/
American Heart Association (ACC/AHA) guidelines published 
in 2014 defined the indications for echocardiography in a dif-
ferent way [4]. It is recommended that patients with clinically 
suspected moderate or greater degrees of valvular stenosis or 
regurgitation undergo preoperative echocardiography if there 
has been (1) no prior echocardiography within 1 year, or (2) 
a significant change in clinical status or physical examination 
since the last evaluation. It is reasonable for patients with dys-
pnea of unknown origin to undergo preoperative evaluation of 
left ventricular (LV) function. It is also reasonable for patients 
with heart failure with worsening dyspnea or other change in 
clinical status to undergo preoperative evaluation of LV func-
tion. Reassessment of LV function in clinically stable patients 
with previously documented LV dysfunction may be considered 
if there has been no assessment within 1 year. However, also in 
these guidelines, routine preoperative evaluation of LV function 
is not recommended.
Under consideration of appropriate indications of preopera-
tive echocardiography in a few current guidelines, we should ap-
ply echocardiography in cost- and time-effective ways in clinical 
practice. Thus, the next step is to assess individual risk based on 
the planned, non-cardiac surgical procedures and to exclude ac-
tive cardiac conditions that are required to undergo evaluation 
and treatment before non-cardiac surgery.
Table 1. Recommendations for Echocardiography before Non-cardiac Surgery Under Current Guidelines
2013 British Society of Echocardiography
    Indicated 
      •  Documented ischemic heart disease with reduced functional capacity (< 4 METs)
      •  Unexplained shortness of breath in the absence of clinical signs of heart failure is ECG and/or CXR abnormal 
      •  Murmur in the presence of cardiac or respiratory symptoms
      •  Murmur in an asymptomatic individual in whom clinical features or other investigation suggest severe structural heart disease 
    Not indicated
      •  Repeat assessment of previous echocardiogram with no intervening change in clinical status 
      •  Routine pre-operative echocardiography 
2011 American Society of Echocardiography guidelines
      •  No clearly defined indication for resting echocardiogram, except for high-risk vascular procedures in patients with reduced functional capacity 
(< 4 METs) where only stress echocardiography is recommended.
2014 American College of Cardiology/American Heart Association guidelines 
      •  It is recommended that the patients with clinically suspected moderate or greater degrees of valvular stenosis or regurgitation undergo 
preoperative echocardiography if there has been (1) no prior echocardiography within 1 year or (2) a significant change in clinical status or 
physical examination since last evaluation (COR I, LOE C) 
      •  It is reasonable for patients with dyspnea of unknown origin to undergo preoperative evaluation of LV function (COR IIa, LOE C) 
      •  It is reasonable for patients with heart failure with worsening dyspnea or other change in clinical status to undergo preoperative evaluation of 
LV function (COR IIa, LOE C) 
      •  Reassessment of LV function in clinically stable patients with previous documented LV dysfunction may be considered if there has been no 
assessment within 1 year (COR IIa, LOE C)
      • Routine preoperative evaluation of LV function is not recommended (COR III: no benefit, LOE B)
METs: metabolic equivalents, ECG: electrocardiogram, CXR: chest X-ray, COR: class of recommendation, LOE: level of evidence, LV: left ventricular.
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Factors to Be Considered When Assessing 
Cardiac Risk 
Cardiac complications after non-cardiac surgery depend 
on patient-related risk factors and on the type of surgery [5,6]. 
Thus, before considering a preoperative cardiac evaluation, in-
cluding echocardiography, individual cardiac risk related to the 
surgical procedures should be assessed [7]. Three factors that 
must be considered are listed in Table 2 [8].
Patient-related factors include age, presence of chronic dis-
ease, functional status, medical history, and the presence of im-
plantable devices or prior surgical history. Regarding functional 
status, a history of daily activities for individuals must be taken. 
If the patient can climb a flight of stairs or walk up a hill, his or 
her metabolic equivalent is > 4 METs. If the patient can partici-
pate in strenuous sports like swimming, singles tennis, football, 
baseball, or skiing, his or her metabolic equivalent is > 10 METs. 
The inability to walk ≥ 2 blocks on level ground or run a short 
distance (< 4 METs) indicates poor functional capacity and is 
associated with an increased incidence of post-operative cardiac 
events [9,10]. Information about functional capacity is impor-
tant in deciding whether to do additional stress testing. It is rea-
sonable for patients who are at an elevated risk for non-cardiac 
surgery and have poor functional capacity (< 4 METs) to un-
dergo non-invasive pharmacological stress testing (dobutamine 
stress echocardiography or pharmacological-stress nuclear im-
aging) under the ACC/AHA guidelines. Advanced age adversely 
affects the rates of cardiac and non-cardiac complications and 
mortality, as well as length of stay. Perioperative mortality risk 
was in the intermediate range (2.6% in patients > 80 years vs. 
0.3% in patients 50–59 years of age, P = 0.02) according to the 
results from a prospective cohort analysis by Polanczyk et al. [11] 
in Brigham & Women’s Hospital. However, there is no reported 
evidence that routine preoperative evaluation using echocar-
diography can improve perioperative outcomes in elderly pa-
tients.
Surgery-related factors include the type of surgery, urgency 
status, surgical duration, and the possibility of blood loss and 
fluid shifts. Table 3 shows the cardiac risk stratification based 
on surgical procedures. Vascular procedures, such as aortic and 
other major vascular surgery are at a high cardiac risk because 
the reported cardiac risk is often > 5% [12,13]. However, en-
doscopic procedures, superficial procedures, cataract surgery, 
breast surgery, and common ambulatory surgeries are at a low 
cardiac risk (< 1%) [14,15]. Most elective non-cardiac surgeries 
are at an intermediate cardiac risk (1–5%).
Finally, before considering specific tests, we need to consider 
test-related factors. Patients, their family members, and even 
surgeons usually believe that the sensitivity and specificity of a 
specific test for cardiac evaluation are 100%. Although this is not 
true, if the results from some specific cardiac test are normal, 
they simply consider the patient’s heart condition to be normal. 
For example, while there is no regional wall motion abnormality 
and normal LV ejection fraction in resting transthoracic echo-
Table 2. Factors to Be Considered When Assessing Cardiac Risk
Patient-related factors
    Age
    Chronic disease (e.g., coronary artery disease, diabetes mellitus, 
      or hypertension)
    Functional status
    Medical history
    Implantable devices
    Previous surgeries  
Surgery-related factors 
    Type of surgery (e.g., vascular, endoscopic, or abdominal)
    Urgency status (e.g., emergency, urgent, or elective)
    Surgical duration, possibility of blood loss and fluid shifts
Test-related factors 
    Sensitivity and specificity of a test
    Effect on management
Table 3. Cardiac Risk Stratification for Non-cardiac Surgical Procedures 
Risk* stratification Procedure examples
High (reported cardiac risk often > 5%) Aortic and other major vascular surgery
Peripheral vascular surgery
Intermediate (reported cardiac risk generally 1–5%) Intraperitoneal and intrathoracic surgery
Carotid endarterectomy
Head and neck surgery 
Orthopedic surgery
Prostate surgery
Low (reported cardiac risk generally < 1%) Endoscopic procedures
Superficial procedure
Cataract surgery
Breast surgery
Ambulatory surgery
*Risk of myocardial infarction and cardiac death within 30 days after surgery.
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cardiography, there are still possibilities for acute coronary syn-
drome, such as unstable angina or non-ST elevation myocardial 
infarction on the LV. Thus, we need to understand the potential 
limitations of non-invasive tests, know the sensitivity and speci-
ficity to identify specific cardiovascular diseases, and consider 
the effects on management. 
Active Cardiac Conditions to Delay  
Non-cardiac Surgery 
Although the risk stratification of patients before non-cardiac 
surgery in stable condition is valuable in preventing cardiac 
events in the perioperative period, the most important purpose 
of preoperative screening is excluding active cardiac conditions. 
Table 4 displays four categories of active cardiac conditions 
[16]. If the patient has one of these conditions, the elective non-
cardiac surgery should be delayed until the patient is out of the 
condition and has become stable.
The four conditions are unstable coronary syndromes, de-
compensated heart failure, significant arrhythmia, and severe 
valvular disease. To define the presence of severe valvular dis-
ease, quantitative measurements of valvular hemodynamics by 
echocardiography are essential. Additionally, to recognize the 
three conditions except severe valvular disease, echocardiog-
raphy is not necessary but valuable in defining the underlying 
cause(s), assessing the severity of each condition, evaluating the 
treatment response, and predicting the prognosis. 
Today, as the aged population grows, the incidence of severe 
aortic stenosis due to degenerative causes will increase. Severe 
aortic stenosis is defined according to an integrative approach 
taking into account valve area (< 1.0 cm2 or 0.6 cm2/m2 body 
surface area, except in obese patients), and flow-dependent in-
dices (maximum jet velocity of 4 m/s and mean aortic pressure 
gradient of ≥ 40 mmHg) [17]. It is often detected during preop-
erative cardiac evaluations. Among the various valvular diseases, 
severe stenotic disease at the aortic valve may affect the clinical 
course seriously during general anesthesia and/or after non-
cardiac surgery [18]. Severe aortic stenosis is a well-established 
risk factor for perioperative mortality and myocardial infarction 
[7]. In cases of urgent non-cardiac surgery in patients with se-
vere aortic stenosis, such procedures should be performed under 
more invasive hemodynamic monitoring, avoiding rapid chang-
es in volume status and heart rhythm as much as possible. In the 
case of elective non-cardiac surgery, the presence of symptoms 
is essential for decision-making [19]. In symptomatic patients, 
aortic valve replacement should be considered before an elective 
surgery [19]. In patients at high risk or contraindicated for aortic 
valve replacement, transcatheter aortic valve implantation may 
be a reasonable therapeutic option before surgery [20,21]. In as-
ymptomatic patients, non-cardiac surgery of low-to-intermedi-
ate risk can be performed. If possible, the absence of symptoms 
should be confirmed by exercise testing. If high-risk surgery is 
planned, further clinical assessment is needed to assess the risk 
of aortic valve replacement [7].
In terms of mitral stenosis, asymptomatic mitral stenosis is 
not absolutely contraindicated but symptomatic mitral stenosis 
should be treated by percutaneous mitral valvuloplasty or mitral 
valve replacement [7]. However, even in asymptomatic patients 
with significant mitral stenosis, systolic pulmonary artery pres-
sure over 50 mmHg is a risk factor for clinical deterioration in 
Table 4. Active Cardiac Conditions That Are Contraindication for Non-cardiac Surgery
Conditions Examples
Unstable coronary syndromes Unstable or severe angina (CCS class III or IV)*
Recent myocardial infarction†
Decompensated heart failure (NYHA functional class IV; 
  worsening or new-onset heart failure)
Significant arrhythmias High-grade atrioventricular block
Mobitz II atrioventricular block
Third-degree atrioventricular heart block
Supraventricular arrhythmias (including atrial fibrillation) with uncontrolled 
  ventricular rate (HR > 100 beats/min at rest)
Symptomatic bradycardia
Newly recognized ventricular tachycardia 
Severe valvular disease Severe aortic stenosis (mean pressure gradient > 40 mmHg, aortic valve area < 1.0 cm2, 
  or symptomatic)
Symptomatic mitral stenosis (progressive dyspnea on exertion, exertional presyncope, 
  or heart failure)
(Adapted from Douglas et al. J Am Soc Echocardiogr 2011;24:229-67). CCS: Canadian Cardiovascular Society, NYHA: New York Heart Association, 
HR: heart rate. *May include “stable” angina in patients who are unusually sedentary. †The American College of Cardiology National Database 
Library defines recent myocardial infarction as > 7 days but ≤ 1 month (within 30 days).
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perioperative periods. Additionally, combined atrial fibrillation 
or tachycardia may cause serious clinical deterioration. Thus, 
use of β-blockers or calcium channel blockers to keep a suffi-
cient diastolic filling time may be helpful in preventing periop-
erative decompensated heart failure.
Cardiac Risk Stratification for Non-cardiac 
Surgical Procedures
If patients do not have an active cardiac condition, those at 
risk for major adverse cardiac events before non-cardiac surgery 
still need to be identified. To stratify cardiac risk, the ACC/AHA 
have created a classification of non-cardiac surgical procedures, 
as shown in Table 3 [3]. In fact, procedures in the intermediate 
category cover a wide range of surgical procedures and carry 
a 1–5% risk of adverse cardiac events. Thus, clinical risk fac-
tors such as a prior history of heart disease, compensated or 
prior heart failure, cerebrovascular disease, diabetes mellitus, 
and renal insufficiency should be dealt with cautiously if the 
procedures are in the intermediate risk categories. If a patient 
has three or more risk factors, a comprehensive cardiovascular 
evaluation should be considered before non-cardiac surgery. 
However, if there are one or two clinical risk factors, a preopera-
tive cardiac evaluation is recommended at the physician’s discre-
tion.
Interpretation of Common Echocardiographic 
Findings
Table 5 lists commonly encountered findings in preopera-
tive echocardiography and their clinical interpretation. These 
findings are somewhat helpful for risk stratification for future 
cardiovascular events. Although many of these findings are 
only subclinical abnormalities or incidental findings, each has 
potential clinical implications. Additionally, if there are some 
discrepancies between individual’s symptoms and echocardio-
graphic findings, clinical correlations by cardiologists or experi-
enced anesthesiologists are important. For example, if a patient 
complains of exertional dyspnea but there are no remarkable 
findings on resting echocardiography, further functional assess-
Table 5. Frequently Encountered Findings in Preoperative Echocardiography 
Echocardiographic findings Interpretation
Left atrial enlargement Degree of left atrial enlargement reflects chronic LV diastolic dysfunction. Patients with left atrial enlargement 
have an increased risk of atrial fibrillation in postoperative periods.
Diastolic dysfunction Patients with advanced diastolic dysfunction are prone to develop heart failure in volume overloaded 
condition ad tachycardia status. 
LV hypertrophy
 
LV hypertrophy itself is not usually problematic, but combined diastolic dysfunction is important (above). 
However, it should be differentiated from hypertrophic cardiomyopathy or infiltrative myocardial disease.
Regional wall motion abnormalities
 
Common causes of regional wall motion abnormalities are ischemic heart disease. Myocardial disease, 
secondary to left bundle branch block, or stress cardiomyopathy should be differentiated from ischemic 
heart disease. 
Systolic dysfunction LV ejection fraction is a representative indicator for LV systolic function. If a patient has systolic dysfunction, 
check E/e’ ratio, reflecting LV filling pressure, and right ventricular systolic pressure for evaluation of heart 
failure status and possibility for the development of decompensated heart failure.
Valvular regurgitation Intraoperative and postoperative hemodynamic monitoring is reasonable in patients with asymptomatic 
severe mitral regurgitation and in patients with asymptomatic severe aortic regurgitation and a normal 
LV ejection fraction. 
Valvular stenosis For patients who meet standard indications for valvular intervention on the basis of symptoms and severity 
of stenosis, valvular intervention before non-cardiac surgery is effective in reducing preoperative risk.
Intraoperative and postoperative hemodynamic monitoring is reasonable in patients with asymptomatic 
severe aortic stenosis and in asymptomatic patients with severe mitral stenosis if valve morphology is not 
favorable for percutaneous mitral balloon commissurotomy. 
Prosthetic valve All patients with prosthetic valves should receive antibiotic prophylaxis before non-cardiac surgery. 
Patients with mechanical valves pose a special problem regarding anticoagulation. 
Pericardial effusion The amount of pericardial effusion and presence of hemodynamic significance, such as constrictive physiology 
or tamponade physiology, are carefully interpreted. Avoiding intracardiac volume depletion and 
monitoring blood pressure and heart rate are crucial in patients with significant amounts of pericardial 
effusion. 
Pulmonary hypertension 
 
The presence of moderate-to-severe pulmonary hypertension is commonly combined with left heart 
disease. Elevation of estimated pulmonary venous pressure can be a sign of decompensated heart failure.
Pulmonary arterial hypertension due to congenital heart disease or idiopathic origin is at a high risk for 
non-cardiac surgery. If a patient has right ventricular systolic pressure over 50 mmHg, consider invasive 
hemodynamic monitoring during and after non-cardiac surgery. 
LV: left ventricle.
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ments using exercise tests should be considered.
When to Perform Stress Echocardiography 
Before Non-cardiac Surgery
There are various types of stress testing for evaluating isch-
emic heart disease. Stress echocardiography using exercise or 
pharmacological (dobutamine, dipyridamole) stress has been 
used widely in preoperative cardiac risk evaluations. The test 
combines information on LV function at rest, heart valve abnor-
malities, and the presence and extent of stress-induced ischemia 
[7,22]. However, before non-cardiac surgery, stress testing is 
mostly focused on the diagnosis and risk stratification of coro-
nary artery disease. For patients with elevated risk and poor (< 4 
METs) or unknown functional capacity, exercise or non-invasive 
pharmacological stress testing for myocardial ischemia is recom-
mended if it will change management. However, routine screen-
ing with non-invasive stress testing is not useful for patients at 
low risk for non-cardiac surgery [3,15].
When stress testing is required to detect myocardial isch-
emia, which stress test should be used? Generally, most ambu-
latory patients commonly undergo a treadmill stress test, but 
exercise echocardiography or nuclear imaging is preferred in pa-
tients with abnormal resting electrocardiograms, including LV 
hypertrophy strain pattern or digitalization effects. In addition, 
patients unable to exercise or patients with left bundle branch 
block on an electrocardiogram should preferably undergo do-
butamine stress echocardiography or nuclear imaging. Thus, the 
stress mode should be selected depending on the clinical situa-
tion to reach an appropriate diagnosis.
A previous meta-analytic comparison of preoperative stress 
echocardiography and nuclear scintigraphy imaging by Beattie 
et al. [23] demonstrated that stress echocardiography had bet-
ter negative predictive characteristics than thallium imaging 
in a comparison of 3,373 subjects who underwent stress echo-
cardiography in 25 studies with 6,827 subjects who underwent 
thallium imaging in 50 studies. Thus, the conclusion was that 
stress echocardiography was superior to thallium imaging in 
predicting postoperative cardiac events. Generally, stress echo-
cardiography has a high negative predictive value and a negative 
test is associated with a very low incidence of cardiac events 
in patients undergoing surgery. In another meta-analysis of 
six non-invasive tests by Kertai et al. [24], dobutamine stress 
echocardiography showed a positive trend towards better diag-
nostic performance versus the other tests, including ambulatory 
electrocardiogram, exercise electrocardiogram, radionuclide 
ventriculography, dipyridamole stress echocardiography, and 
myocardial perfusion scintigraphy.
Focused Echocardiography for Preoperative 
Cardiac Evaluation 
Recently, interest in focused echocardiography has increased 
for evaluating cardiac status effectively for a specific goal. Partic-
ularly, increased availability, portability, and imaging capabilities 
of current transthoracic echocardiography equipment has en-
abled treating physicians to perform their own ‘focused echocar-
diography’ as an aid to an initial clinical assessment at the point 
of care, when required. For example, aortic stenosis, common 
in the hip fracture population, and pulmonary hypertension are 
significant risk factors for mortality, but diagnosis is unreliable 
without echocardiography. Thus, focused echocardiography 
may provide a more accurate assessment than a physical exami-
nation alone. Attractively, it is usually performed at the patient’s 
bedside as a point of care.
A prospective observational study by Canty et al. [25] dis-
cussed focused transthoracic echocardiography in 99 patients 
who had suspected cardiac disease or were ≥ 65 years old. Fo-
cused echocardiography included only a few important points 
of LV or right ventricular failure, valve stenosis, or regurgita-
tion of at least moderate severity, pericardial effusion greater 
than 0.5 cm, and estimated pulmonary arterial systolic pressure 
> 60 mmHg. In that study, cardiac disease was identified by 
echocardiography in 64% of patients, which led to a step-up of 
treatment in 36% (4% delayed for cardiology referral, 2% altered 
surgery, 4% intensive care, and 25% intra-operative hemody-
namic management changes). Absence of cardiac disease in 36% 
resulted in a step-down of treatment in 8% (3% no referral, 1% 
intensive care, and 4% hemodynamic treatment). Although fur-
ther studies are warranted, focused echocardiography is a valu-
able method for preoperative cardiac risk stratification.
Conclusions
In the current guidelines, routine preoperative cardiac evalu-
ation by echocardiography is not recommended for everyone, 
given the considerations of cost-effectiveness and time delay 
for non-cardiac surgery. Preoperative echocardiography has 
become more popular in clinical practice because it can provide 
clinically useful information about a patient’s cardiac risk. Thus, 
understanding the commonly encountered echocardiographic 
findings and clinical interpretations are helpful for managing 
patients in the perioperative period. 
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